marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Lineage Cell Therapeutics Financial Statements 2011-2024 | LCTX
Annual Financial Statements Lineage Cell Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
192 M | 243 M | 232 M | 331 M | 156 M | 180 M | 339 M | 294 M | 193 M | 271 M | 209 M | 222 M | 279 M |
Shares |
173 M | 170 M | 165 M | 150 M | 146 M | 127 M | 114 M | 97.3 M | 79.7 M | 66.5 M | 54.2 M | 49.2 M | 47.5 M |
Historical Prices |
1.11 | 1.43 | 1.41 | 2.3 | 1.01 | 1.2 | 2.62 | 3.25 | 2.3 | 4.2 | 3.59 | 4.21 | 4.99 |
Net Income |
-4.78 M | -6.35 M | -29 M | -20.6 M | -11.7 M | -46 M | -20 M | 33.6 M | -47 M | -36.4 M | -43.9 M | -21.4 M | -16.5 M |
Revenue |
2.09 M | 1.92 M | 1.17 M | 1.83 M | 3.52 M | 4.99 M | 3.46 M | 5.92 M | 7.04 M | 5.24 M | 4.43 M | 3.92 M | 4.35 M |
Cost of Revenue |
671 K | 728 K | 1.43 M | 385 K | 412 K | 302 K | 168 K | 358 K | 1.11 M | 837 K | 793 K | 434 K | 79.4 K |
Gross Profit |
8.27 M | 14 M | 2.92 M | 1.44 M | 3.1 M | 4.69 M | 3.29 M | 5.56 M | 5.93 M | 4.41 M | 3.64 M | 3.48 M | 4.35 M |
Operating Income |
-6.36 M | -6.64 M | -28.2 M | -26.4 M | -38.9 M | -41.8 M | -38.9 M | -59 M | -65.8 M | -50.7 M | -56 M | -25 M | -18.7 M |
Interest Expense |
-4 K | -2.15 M | 1.49 M | 2.88 M | 2.53 M | -1.7 M | 1.45 M | -403 K | -160 K | -384 K | -204 K | 19.4 K | 29.7 K |
EBITDA |
-5.8 M | -6.06 M | -27.6 M | -24.3 M | -35.7 M | -37.7 M | -37.4 M | -54.2 M | -59.5 M | -42.3 M | -34.6 M | -22.2 M | -16.3 M |
Operating Expenses |
8.19 M | 8.45 M | 29.2 M | 27.9 M | 42 M | 45.7 M | 43.9 M | 64.5 M | 71.7 M | 55.1 M | 42.2 M | 28.5 M | 23 M |
General and Administrative Expenses |
17.3 M | 22.5 M | 18.2 M | 15.6 M | 24 M | 24.7 M | 19.9 M | 28.4 M | 29.1 M | 17.6 M | 15.6 M | 10.4 M | - |
All numbers in USD currency
Quarterly Income Statement Lineage Cell Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
189 M | 189 M | 183 M | 175 M | 175 M | 171 M | 170 M | 170 M | 170 M | 170 M | 170 M | 169 M | 168 M | 163 M | 159 K | 153 M | 150 M | 150 K | 150 M | 150 M | 150 M | 150 M | 133 M | 127 M | 127 M | 127 M | 127 M | 127 M | 115 M | 111 M | 107 K | 103 M | 103 K | 93.2 K | 90.4 K | 90.4 M | 79.2 K | 78.4 K | 78.3 M | 78.2 M | 67.9 M | 61.5 M | 58.3 M | 56.7 M | 55.6 M | 53.8 M | 51.2 M | 49.4 M | 49.3 M | 50.5 M | 49 M | 49 M | 48.9 M | 48.8 M | 49 M |
Net Income |
-3.03 M | -5.76 M | -6.54 M | - | -7.11 M | -5.23 M | -4.37 M | - | -6.07 M | -6.76 M | -7.09 M | -29 M | -7.82 M | -4.8 M | -1.45 M | 2.03 M | -7.76 M | -6.52 M | -8.4 M | -4.48 M | -16.5 M | -30 M | 39.3 M | -45 M | 66.7 M | -4.22 M | -63.5 M | -71.9 M | 14.3 M | -11.7 M | 49.3 M | -4.94 M | 31.2 M | 24.5 M | -17.1 M | -13.5 M | -13.6 M | -9.69 M | -10.2 M | -10.6 M | -8.27 M | -9.52 M | -8.1 M | -19.6 M | -9 M | -7.55 M | -7.72 M | -6.04 M | -4.96 M | -5.46 M | -4.97 M | -5.14 M | -3.74 M | -4.28 M | -3.36 M |
Revenue |
3.78 M | 1.41 M | 1.44 M | - | 1.25 M | 3.22 M | 2.39 M | - | 3 M | 4.55 M | 5.24 M | 1.17 M | 2.27 M | 512 K | 391 K | 355 K | 571 K | 386 K | 514 K | 1.24 M | 567 K | 779 K | 928 K | 758 K | 982 K | 2.55 M | 701 K | 945 K | 1.64 M | 376 K | 390 K | 1.1 M | 1.5 M | 1.27 M | 2.07 M | 1.31 M | 2.31 M | 2.01 M | 1.26 M | 1.66 M | 1.19 M | 1.11 M | 1.07 M | 1.67 M | 714 K | 1.22 M | 614 K | 1.07 M | 1 M | 1.03 M | 652 K | 1.63 M | 1.14 M | 756 K | 825 K |
Cost of Revenue |
38 K | 44 K | 98 K | - | 169 K | 127 K | 119 K | - | 235 K | 215 K | 176 K | - | 985 K | 125 K | 112 K | - | 102 K | 75 K | 94 K | - | 114 K | 107 K | 68 K | - | 35 K | 106 K | 109 K | - | 52 K | 5 K | 57 K | - | 58 K | 95 K | 225 K | - | 432 K | 260 K | 264 K | - | 231 K | 252 K | 132 K | - | 207 K | 181 K | 183 K | - | 170 K | 83.9 K | 20.3 K | - | 18.5 K | 24.8 K | - |
Gross Profit |
- | - | - | - | 1.08 M | 3.1 M | 2.27 M | - | 2.76 M | 4.34 M | 5.06 M | - | 1.28 M | 387 K | 279 K | - | 469 K | 311 K | 420 K | - | 453 K | 672 K | 860 K | - | 947 K | 2.44 M | 592 K | - | 1.64 M | 376 K | 333 K | - | 1.44 M | 1.17 M | 1.85 M | - | 1.87 M | 1.75 M | 1 M | - | 960 K | 855 K | 935 K | - | 507 K | 1.04 M | 432 K | - | 834 K | 950 K | 632 K | - | 1.14 M | 756 K | - |
Operating Income |
-3.84 M | -5.87 M | -6.66 M | - | -6.7 M | -5.02 M | -6.64 M | - | -5.25 M | -4.23 M | -6.4 M | -28.2 M | -6.84 M | -7.08 M | -7.05 M | -5.88 M | -6.72 M | -6.4 M | -7.44 M | -6.87 M | -8.42 M | -10.8 M | -12.8 M | -10.1 M | -10.4 M | -9.14 M | -12.2 M | -9.56 M | -9.51 M | -8.56 M | -11.3 M | -11.3 M | -9.56 M | -14.4 M | -23.8 M | -21.7 M | -17.1 M | -13.5 M | -13.5 M | -14.4 M | -12.1 M | -13.1 M | -11.1 M | -29.3 M | -10.2 M | -8.12 M | -8.38 M | -7.06 M | -5.95 M | -6.08 M | -5.92 M | -5.45 M | -4.23 M | -4.98 M | -4.03 M |
Interest Expense |
- | 19 K | - | - | 1 K | 86 K | 457 K | - | -475 K | -1.89 M | -184 K | - | 393 K | 970 K | -1.68 M | - | 351 K | 1.17 M | -1.35 M | - | 582 K | 882 K | 806 K | - | -7 K | -839 K | -176 K | - | -143 K | 617 K | 727 K | - | -173 K | 237 K | 128 K | - | -573 K | 225 K | -240 K | - | -119 K | -10 K | -8.38 K | - | 509 | 579 | 943 | - | 22.9 K | 85.1 K | 8.3 K | - | -4.25 K | -19.3 K | 13.2 K |
EBITDA |
-3.7 M | -5.72 M | -6.51 M | - | -6.56 M | -4.89 M | -6.5 M | - | 140 M | 142 M | -6.25 M | -28.2 M | -6.34 M | -6.74 M | -6.88 M | -5.88 M | -6.52 M | -6.19 M | -7.23 M | -6.87 M | -8.17 M | -10.6 M | -12.5 M | -10.1 M | -10.1 M | -8.86 M | -11.9 M | -9.56 M | -9.26 M | -8.36 M | -11 M | -11.3 M | -8.56 M | -13.7 M | -23.3 M | -21.7 M | -16.3 M | -13 M | -13.2 M | -14.4 M | -11.3 M | -12.5 M | -10.9 M | -29.3 M | -9.78 M | -8 M | -8.27 M | -7.06 M | -5.66 M | -5.99 M | -5.83 M | -5.45 M | -3.97 M | -4.85 M | -3.96 M |
Operating Expenses |
- | - | - | - | 7.78 M | 8.12 M | 8.91 M | - | 8.01 M | 8.57 M | 11.5 M | 29.2 M | 8.13 M | 7.47 M | 7.33 M | 6.12 M | 7.19 M | 6.71 M | 7.86 M | 7.99 M | 8.88 M | 11.5 M | 13.6 M | 10.8 M | 11.3 M | 11.6 M | 12.8 M | 10.5 M | 11.1 M | 10.7 M | 11.6 M | 12.4 M | 11 M | 15.6 M | 25.6 M | 23 M | 19 M | 15.2 M | 14.5 M | 16.1 M | 13.1 M | 13.9 M | 12.1 M | 13.5 M | 10.7 M | 9.15 M | 8.81 M | 8.12 M | 6.78 M | 7.03 M | 6.55 M | 7.08 M | 5.38 M | 5.74 M | 4.85 M |
General and Administrative Expenses |
4.41 M | 4.36 M | 5 M | - | 4.04 M | 4.25 M | 4.72 M | - | 4.42 M | 5.27 M | 8.47 M | - | 5.32 M | 4.54 M | 3.94 M | - | 3.63 M | 3.91 M | 4.52 M | - | 4.61 M | 6.26 M | 8.66 M | - | 6.42 M | 5.23 M | 6.04 M | - | 4.59 M | 4.42 M | 5.1 M | - | 4.57 M | 6.64 M | 11.9 M | - | 7.54 M | 6.19 M | 5.18 M | - | 4.26 M | 4.84 M | 3.67 M | - | 4.27 M | 3.62 M | 3.42 M | - | 2.23 M | 2.41 M | 2.37 M | - | 1.89 M | 2.4 M | 1.9 M |
All numbers in USD currency